Glenview Capital Management, LLC cut its stake in Alight, Inc.(NYSE:ALIT) by 4,004,556 shares in the third quarter, reducing exposure by an estimated $71.57 million, according to a November 14, 2025, ...
Mizuho analyst Ann Hynes raised the firm’s price target on CVS Health (CVS) to $95 from $88 and keeps an Outperform rating on the shares, telling ...
Bernstein raised the firm’s price target on CVS Health (CVS) to $87 from $86 and keeps a Market Perform rating on the shares following overall a ...
Snopes readers regularly ask whether supplement brands like Neurocept and Burn Peak are legit. Here's how you can tell yourself.